Boston, MA -- (SBWIRE) -- 05/22/2017 -- Anxiety is a normal reaction to stress, which helps to deal with tense situations. However, when anxiety becomes an excessive and irrational extension of everyday situations, it turns into disorder as per medical definition. Panic attacks, a type of anxiety disorder, are associated with sudden episodes of emotions of fear and anxiety.

Technavio's analysts forecast the global anxiety and panic disorders drugs market to grow at a CAGR of 1.78 % during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global anxiety and panic disorders drugs market for 2017-2021. To calculate the market size, the report considers the sales from both branded and generic drugs.

Get More Details on this Report and a Full Table of Contents at Global Anxiety and Panic Disorders Drugs Market 2017-2021

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Anxiety and Panic Disorders Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AstraZeneca
-Eli Lilly
-GlaxoSmithKline
-Pfizer

Other prominent vendors

-Azevan Pharmaceuticals
-Baxter
-Bristol-Myers Squibb
-F. Hoffman-La Roche

Market driver

-Increasing stress in day-to-day life
-For a full, detailed list, view our report

Market challenge

-Availability of electroceuticals
-For a full, detailed list, view our report

Market trend

-Synergistic effects of medication aided with neuromodulation devices
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AstraZeneca, Eli Lilly, GlaxoSmithKline, Pfizer, Azevan Pharmaceuticals, Baxter, Bristol-Myers Squibb, F. Hoffman-La Roche

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016
-Global Central Nervous System Disorders Therapeutics Market 2016-2020
-Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
-Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
-Global Musculoskeletal Disorders Therapeutics Market 2016-2020